- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 275/34 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
Patent holdings for IPC class C07C 275/34
Total number of patents in this class: 90
10-year publication summary
4
|
12
|
10
|
7
|
7
|
8
|
6
|
5
|
6
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Board of Trustees of the University of Illinois | 2693 |
5 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 922 |
5 |
Arena Pharmaceuticals, Inc. | 367 |
4 |
Firmenich Incorporated | 144 |
4 |
Reata Pharmaceuticals Holdings, LLC | 47 |
4 |
Bristol-myers Squibb Company | 4896 |
3 |
The Regents of the University of California | 19784 |
3 |
The General Hospital Corporation | 4700 |
3 |
Toray Industries, Inc. | 6867 |
3 |
University of Oregon | 187 |
3 |
Duke University | 3056 |
2 |
Arete Therapeutics, Inc. | 23 |
2 |
Nippon Soda Co., Ltd. | 889 |
2 |
The Research Foundation for The State University of New York | 1598 |
2 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3115 |
2 |
Glaxosmithkline LLC | 538 |
1 |
Bristol-myers Squibb Pharma Company | 23 |
1 |
Merck Patent GmbH | 5831 |
1 |
Abbott Laboratories | 2416 |
1 |
Allergan, Inc. | 2362 |
1 |
Other owners | 38 |